Shareholders Turn Down Tender Offer to Take BioCanCell Private Post author:Sam Post published:December 27, 2017 Post category:BioPharma Approximately 5.9 million shares were necessary for the tender to be accepted. Source: BioSpace You Might Also Like Pfizer, Arvinas Forge $830M Protein Degradation R&D Deal January 3, 2018 Tax Reform Could Lead to Spike in Biopharma M&A Activity February 22, 2018 Norwegian Biotech Upstart Has Become a Potential Takeover Target February 19, 2017
